CEO and others buying at Tetra Bio-Pharma (TBP)

CEO and others buying at Tetra Bio-Pharma (C:TBP)

Guy Chamberland, CEO, acquired 84,000 Common Shares on a direct ownership basis at a price of $0.300 through a prospectus or prospectus exempt offering on August 2nd, 2019. The insider also acquired 84,000 Warrants on a direct ownership basis with an exercise price of $0.400 for 36 months. This represents a $25,200 investment into the company's shares and an account share holdings change of greater than 100%.

Six other insiders also reported participating in the deal.
Tetra Bio-Pharma is in the Pharmaceuticals Sub Industry Group under the Healthcare Sector.

Tetra Bio Pharma Inc is a Canada-based company engaged in the development of bio pharmaceuticals and natural health products containing cannabis and other medicinal plant based elements. The Company is focused on combining the traditional methods of medicinal cannabis use with the supporting scientific validation and safety data required for inclusion into the existing bio pharma industry by regulators physicians and insurance companies. The Company objective is to bring smokable, natural medical marijuana to the market along with a number of other products targeting chronic pain, insomnia, post-traumatic stress disorder (PTSD), anxiety, among others. The Company operates through three divisions: PhytoPain Pharma Inc, Agro Tek Health and Grow Pros Cannabis Ventures Inc.